復星醫藥(02196.HK)非公開發行A股申請獲中國證監會核准批覆
格隆匯8月2日丨復星醫藥(02196.HK)發佈公吿,公司於近日收到中國證監會出具的《關於核准上海復星醫藥(集團)股份有限公司非公開發行股票的批覆》(證監許可[2021]2501號),批覆主要內容如下:
一、核准公司非公開發行不超過128,144,927股新股(A股),發生轉增股本等情形導致總股本發生變化的,可相應調整本次發行數量。
二、本次發行股票應嚴格按照本公司報送中國證監會的申請文件實施。
三、本批覆自核準發行之日(即2021年7月27日)起12個月內有效。
四、自核準發行之日起至本次股票發行結束前,本公司如發生重大事項,應及時報吿中國證監會並按有關規定處理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.